First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group

Marinde J. G. Bond, Johanneke H.M.J.V. Vestjens, T. Chapelle et al.|The Lancet Oncology|2023

Cited by 168